tradingkey.logo
tradingkey.logo
Suchen

Prenetics Global Ltd

PRE
Zur Watchlist hinzufügen
16.930USD
-0.960-5.37%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
287.82MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Prenetics Global Ltd Unternehmen

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.

Prenetics Global Ltd Informationen

BörsenkürzelPRE
Name des UnternehmensPrenetics Global Ltd
IPO-datumJul 06, 2021
CEOKwok (Samantha)
Anzahl der mitarbeiter285
WertpapierartOrdinary Share
GeschäftsjahresendeJul 06
AddresseUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
Stadt
BörseNASDAQ OMX - NASDAQ BASIC
LandHong Kong
Postleitzahl- -
Telefon85222109588
Websitehttps://ir.prenetics.com/
BörsenkürzelPRE
IPO-datumJul 06, 2021
CEOKwok (Samantha)

Führungskräfte von Prenetics Global Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Joel Neoh
Mr. Joel Neoh
Chief Consumer Officer, Chief Executive Officer of CircleDNA
Chief Consumer Officer, Chief Executive Officer of CircleDNA
--
--
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Prenetics Global Ltd?

Die fünf größten Anteilseigner von Prenetics Global Ltd sind: Mr. Sheng Wu (Danny) Yeung

Wie viele Institutionen halten Anteile an Prenetics Global Ltd (PRE)?

Mit Stand vom 2026Q1 halten 46 Institutionen Anteile an Prenetics Global Ltd, mit einem Gesamtmarktwert von etwa 1.76M, was 11.33% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -778478.00 gestiegen.